Published on October 28, 2015

 Mayor Janice S. Mironov announced that Aurobindo Pharma USA received Township Planning Board approval at the October 26 meeting, to construct a 567,000 square foot pharmaceutical, warehouse, distribution, manufacturing, center, on Windsor Center Drive, across from Route 133 and near the 43,000 square foot Patscentre building, occupied by another pharmaceutical company.

The new facility will generate significant new tax dollars andapproximately 400 to 500 new jobs at the East Windsor location, when fully operational. The East Windsor project is to expand Aurobindo's New Jersey footprint for manufacturing and warehousing and is complementary to the company's existing facilities.

Mayor Mironov stated, “We are excited that Aurobindo has chosen East Windsor for their new warehouse, distribution and manufacturing, center, bringing additional tax dollars and a large number of new jobs to our community.” Mayor Mironov continued, “This expansion here by Aurobindo, a global corporation, represents the attraction to East Windsor of another high-tech, high growth-potential company in our Einstein’s Alley corridor. East Windsor is a great location for this type of company, and we are pleased to add Aurobindo to the many pharmaceutical related firms which have chosen to locate in East Windsor, including Accelis, Hovione, Elementis, CoreTech Solutions, Aprecia, Aurex Laboratories, Sabinsa, and Windsor Labs.”

Mayor Mironov added, “This new acquisition and proposed facility highlights the Township’s strong business appeal and the tremendous benefits of this commercial site which, with the Turnpike improvements, now also enjoys direct access by way of Route 133 to East Windsor Turnpike Interchange 8.”

Aurobindo USA’s Chief Executive Officer Robert Cunard stated, “We at Aurobindo Pharma are very excited about our planned expansion into East Windsor. We have appreciated the valuable assistance and guidance of the Mayor and her team, who have been great partners and extremely helpful to our company in moving forward with our planned expansion in New Jersey.”. Mr. Cunard added, “We look forward to a long and successful collaboration, and becoming a member of the East Windsor business community. East Windsor is a perfect location for Aurobindo’s goal of an expanded U.S. and New Jersey presence.”

Headquartered in HITEC City, Hyderabad, India, founded in 1986 and becoming a public company in 1992, Aurobindo has business operations in over 125 countries around the world. Aurobindo Pharma USA is a generic pharmaceutical manufacturer and distributor and is a wholly-owned subsidiary of Aurobindo Pharma Limited, a leading generic pharmaceutical company based in India.